Abbott Laboratories (ABT) Financials
Abbott Laboratories (ABT) Historical Financial Statements and Key Metrics for 1985 - 2025
Full Abbott Laboratories financials for 1985 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbott Laboratories Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Mar-31 | 10,358 | 5,890 (56.9 %) | 1,693 (16.3 %) | 1,325 (12.8 %) | 2,665 | 0.76 |
| 2024-Dec-31 | 10,974 | 6,032 (55.0 %) | 1,911 (17.4 %) | 9,229 (84.1 %) | 2,989 | 5.27 |
| 2024-Sep-30 | 10,635 | 5,937 (55.8 %) | 1,859 (17.5 %) | 1,646 (15.5 %) | 2,907 | 0.94 |
| 2024-Jun-30 | 10,377 | 5,807 (56.0 %) | 1,723 (16.6 %) | 1,302 (12.5 %) | 1,723 | 0.74 |
| 2024-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Sep-30 | 10,143 | 5,538 (54.6 %) | 1,647 (16.2 %) | 1,436 (14.2 %) | 2,226 | 0.82 |
Full historical income statements for 1985 - 2025 is included in the
US Historical Financials dataset.
Abbott Laboratories Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Mar-31 | 81,448 | 32,384 | 13,242 | 48,811 | 6,844 |
| 2024-Dec-31 | 81,414 | 33,513 | 15,021 | 47,664 | 7,967 |
| 2024-Sep-30 | 74,356 | 34,328 | 14,979 | 39,796 | 7,788 |
| 2024-Jun-30 | 73,017 | 33,457 | 14,754 | 39,318 | 7,219 |
| 2024-Mar-31 | 72,467 | 33,424 | 14,586 | 38,810 | 6,651 |
| 2023-Dec-31 | 73,214 | 34,387 | 15,873 | 38,603 | 7,279 |
| 2023-Sep-30 | 72,090 | 213 | 15,528 | 71,877 | 7,047 |
Full historical balance sheet data for 1985 - 2025 is included in the
US Historical Financials dataset.
Abbott Laboratories Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Mar-31 | 1,417 | -470 | -2,055 | 933 |
| 2024-Dec-31 | 2,868 | -866 | -1,861 | 2,148 |
| 2024-Sep-30 | 2,705 | -594 | -1,576 | 2,149 |
| 2024-Jun-30 | 1,960 | -453 | -791 | 1,427 |
| 2024-Mar-31 | 1,025 | -425 | -1,176 | 627 |
| 2023-Dec-31 | 3,038 | -824 | -2,052 | 2,283 |
| 2023-Sep-30 | 0 | 0 | 0 | 0 |
Full historical cash flow data for 1985 - 2025 is included in the
US Historical Financials dataset.
Abbott Laboratories Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Mar-31 | 231,769 | 238,479 | 22.38 | 43.73 | 4.75 |
| 2024-Dec-31 | 195,872 | 203,277 | 17.85 | 5.31 | 4.11 |
| 2024-Sep-30 | 197,745 | 205,166 | 18.59 | 30.03 | 4.97 |
| 2024-Jun-30 | 178,957 | 186,724 | 17.25 | 34.36 | 4.55 |
| 2024-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Sep-30 | 168,069 | 176,888 | 16.57 | 29.26 | 2.34 |
Full historical valuation and operating metrics for 1985 - 2025 are included in the
US Historical Financials dataset.